Axa’s Tyra Biosciences TYRA Stock Holding History

Axa’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-128,400	Closed	-$1.23M	–	954
2025 Q2	$1.23M	Buy	128,400 +211	+0.2%	+$2K	﹤0.01%	854
2025 Q1	$1.19M	Buy	+128,189	New	+$1.66M	﹤0.01%	822

Other funds holding TYRA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

APMC

Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

CPX

Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Axa's TYRA Position: Q3 2025 in Review

Axa sold out of Tyra Biosciences (TYRA) in Q3 2025, closing a stake of 128,400 shares — an estimated $1.23M sold.

Axa first reported a position in TYRA in Q1 2025 and held it in 2 quarters. The position peaked at $1.23M in Q2 2025. 116 funds tracked by Wall St. Rank hold TYRA as of Q3 2025.

Axa reported no remaining Tyra Biosciences position as of Q3 2025 after selling out during the quarter.
Axa sold 128,400 Tyra Biosciences shares in Q3 2025, an estimated $1.23M.
Axa first reported a position in Tyra Biosciences in Q1 2025 and held it in 2 quarters.
Axa's Tyra Biosciences position peaked at $1.23M in Q2 2025.
116 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.